Login

James P. Scriven, CEO of IDB Invest, explores Latin American finance and investment strategies with the International Finance Corporation. 00:10:00

Share On Facebook Share On Twitter

James P. Scriven, CEO of IDB Invest

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:00:00
4d pharma reveals 'phenomenal results' from early stage cancer trial - Duncan Peyton, CEO, 4D Pharma
00:10:00
Talent to build great companies can come from anywhere|Jixun Foo,Global Managing Partner,GGV Capital
00:10:00
Strategic Leadership in Private Equity and Infrastructure - Partner & Chairman of the Global Advisory Board at Campbell Lutyens
00:10:00
Expansion and Growth: Bass Metals' Strategic Overview and Future Prospects
00:10:00
Avenir Telecom switches to a B2B model. | Robert Schiano Lamoriello, CEO, Avenir Telecom SAAVT:PAR
00:10:00
Data#3 & Cisco's Award-Winning Partnership | Brad Colledge, CEO, Data#3 LtdDTL:ASX
00:10:00
Advancing Sustainability and Growth at Mountain Province Diamonds
00:10:00
Blade Strategy and Business Model: Transforming Vertical Mobility | Rob Wiesenthal, CEO, Blade Air Mobility, Inc.
00:10:00
The Four-Step Process of Personal Financial Planning for Executives and Attorneys
00:10:00
Cobalt Blue Holdings CEO Joe Kaderavek on Broken Hill Project and Strategic Partnerships.
00:10:00
Raising the Bar for Brazilian E-Commerce: Fernando Cirne, CEO of Locaweb | Fernando Cirne, CEO , Locaweb Serviços De Internet SA.
00:00:00
ProMIS Neurosciences reckons it has the only assets to tackle - Eugene William , Promis Neurosciences Inc

© 2026 Nehu